Stock Fundamentals

Company Information

Company Name
Dyne Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US26818M1080
CIK: 0001379895
CUSIP: 26817G300
Currency: USD
Full Time Employees: 263
Phone: 781 786 8230
Fiscal Year End: December
IPO Date: Sep 17, 2020
Description:

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Address:

1560 Trapelo Road, Waltham, MA, United States, 02451

Directors & Officers

Name Title Year Born
Mr. John G. Cox M.B.A. CEO, President & Director 1963
Mr. Erick J. Lucera C.F.A., CPA CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer 1968
Dr. Oxana Beskrovnaya Ph.D. Chief Innovation Officer 1961
Ms. Johanna Friedl-Naderer Chief Commercial Officer 1968
Dr. Douglas Kerr M.B.A., M.D., Ph.D. Chief Medical Officer 1967
Dr. Axel Wiest Senior VP and Head of Portfolio Strategy & Operations NA
Dr. Rajesh Manchanda Ph.D. Chief Technical Officer 1967
Mr. James P. Bilotta M.B.A. Chief Digital & Information Officer NA
Mr. Daniel Wilson Senior VP & Head of Legal 1972
Ms. Lucia Celona Chief Human Resource Officer 1966

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 22, 2026 Jason P Rhodes N/A Sale 287.96K $19.68 $5.67M
Apr 21, 2026 Jason P Rhodes N/A Sale 274.30K $19.52 $5.35M
Apr 20, 2026 Jason P Rhodes N/A Sale 272.05K $20.06 $5.46M
Mar 06, 2026 Brian S Posner N/A Purchase 3.00K $15.06 $45.18K
Sep 05, 2025 John Cox N/A Sale 2.64K $13.41 $35.40K
Jul 14, 2025 John Cox N/A Purchase 100.00K $9.11 $911.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
T. Rowe Price Investment Management,Inc. 30.79M Mar 31, 2026 18.63% $0.38 50.83%
HHG PLC 13.65M Mar 31, 2026 8.26% $0.12 -1.73%
BlackRock Inc 11.70M Mar 31, 2026 7.08% $0.00 4.55%
Vanguard Group Inc 11.22M Dec 31, 2025 6.79% $0.00 14.91%
Atlas Venture Life Science Advisors, LLC 9.13M Mar 31, 2026 5.53% $20.95 0.00%
FMR Inc 8.91M Mar 31, 2026 5.39% $0.01 35.60%
Orbis Allan Gray Ltd 6.76M Mar 31, 2026 4.09% $0.52 40.82%
State Street Corp 6.65M Mar 31, 2026 4.03% $0.00 -0.58%
Perceptive Advisors LLC 4.67M Mar 31, 2026 2.83% $1.66 34.20%
FCPM III SERVICES BV 4.64M Mar 31, 2026 2.81% $11.66 -14.98%
TCG Crossover Management, LLC 4.62M Mar 31, 2026 2.79% $2.39 0.00%
Vestal Point Capital LP 4.00M Mar 31, 2026 2.42% $2.03 3,233.33%
Geode Capital Management, LLC 3.50M Mar 31, 2026 2.12% $0.00 7.38%
JPMorgan Chase & Co 3.25M Mar 31, 2026 1.97% $0.00 -8.35%
Armistice Capital, LLC 3.18M Mar 31, 2026 1.92% $1.02 -2.30%
Frazier Life Sciences Management, L.P. 3.15M Mar 31, 2026 1.91% $1.47 0.00%
Orbimed Advisors, LLC 2.92M Mar 31, 2026 1.77% $1.05 32.50%
T. Rowe Price Associates, Inc. 2.33M Mar 31, 2026 1.41% $0.00 0.20%
Siren, L.L.C. 2.23M Mar 31, 2026 1.35% $1.12 -36.36%
VR Adviser, LLC 2.17M Mar 31, 2026 1.32% $1.47 0.00%

Shares Statistics

Shares Outstanding: 165.31M
Shares Float: 164.74M
% Insiders: 27.80%
% Institutions: 11,545.70%
Short % Float: 16.84%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 T. Rowe Price US Small-Cap Core Equity 7.01M 4.24% ▲ 28.94% Mar 31, 2026
2 T. Rowe Price Small-Cap Stock 7.01M 4.24% ▲ 27.11% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 4.71M 2.85% ▲ 1.28% Apr 30, 2026
4 T. Rowe Price Small-Cap Value 4.63M 2.80% ▲ 6.98% Mar 31, 2026
5 State Street® SPDR® S&P® Biotech ETF 3.84M 2.33% ▼ 0.71% Apr 30, 2026
6 T. Rowe Price Instl Small-Cap Stock 3.81M 2.31% ▲ 26.48% Mar 31, 2026
7 T. Rowe Price U.S. SC Core Eq Tr-D 3.38M 2.05% ▲ 32.01% Mar 31, 2026
8 T. Rowe Price Capital Appreciation 3.28M 1.99% ▲ 0.00% Mar 31, 2026
9 iShares Russell 2000 ETF 3.13M 1.89% ▲ 0.85% Apr 30, 2026
10 T. Rowe Price U.S. SC Value Eq Tr-D 3.00M 1.81% ▲ 90.96% Mar 31, 2026

Valuation Metrics

Enterprise Value: $2.28B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.97B
EBITDA: $-468.99M
PEG Ratio: $0.19
Book Value: $5.89
Earnings/Share: $-3.15
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -32.70%
ROE (TTM): -58.89%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 22.25x 0.16x 0.18x -75.61x -0.35x
2024-12-31 15.60x 0.01x 0.09x N/A -0.02x
2023-12-31 2.53x 0.05x 0.45x N/A -0.02x
2022-12-31 9.46x 0.02x 0.18x -58.61x -0.03x
2021-12-31 13.31x 0.01x 0.14x -202.19x -0.03x
2020-12-31 31.83x 0.00x 0.03x -148.10x 0.00x
2019-12-31 6.26x 0.00x 0.15x -47.68x 0.00x
2018-12-31 11.47x 0.00x 1.59x -959.00x 0.00x
2017-12-31 1.45x 0.06x 0.84x -0.67x 0.11x
2016-12-31 3.26x 0.10x 0.84x -1.02x 1.90x
2015-12-31 2.40x 0.03x 0.75x 0.12x 0.11x
2014-12-31 3.93x 0.01x 0.73x -4.75x 0.11x
2013-12-31 2.34x 0.01x 0.58x -3.28x 0.09x
2012-12-31 3.01x 0.01x 0.45x N/A 0.26x
2011-12-31 4.23x 0.00x 0.73x -0.66x 0.00x
2010-12-31 1.43x 0.05x 0.73x -0.03x 0.20x
2009-12-31 1.10x 0.28x 0.73x -2.01x -4.66x
2008-12-31 1.65x 0.01x 0.68x 1.66x 0.07x
2007-12-31 1.66x 0.01x 0.66x 1.58x 0.06x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DYN.US!